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In the present data article, lamprey cysteine-rich buccal gland
protein (CRBGP) which belongs to cysteine-rich secretory proteins
(CRISPs) family was recombinant and expressed in Rosetta blue
cells. After identiﬁcation, the recombinant protein was puriﬁed
through afﬁnity chromatograph. The inhibition effects of recom-
binant lamprey CRBGP (rL-CRBGP) on tube formation of human
umbilical vein endothelial cells (HUVECs) and new blood vessel
generation in chick chorioallantoic membrane (CAM) models were
analyzed. This paper contains data related to research concurrently
published in “Anti-angiogenic activities of CRBGP from buccal
glands of lampreys (Lampetra japonica)” [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Speciﬁcations tableubject area Biology
ore speciﬁc sub-
ject areaBiochemistryvier Inc. This is an open access article under the CC BY license
/j.biochi.2015.11.020
ao1980@126.com (R. Xiao).
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ow data was
acquiredMicroscope, mass spectroscopy, cameraata format Raw and analyzed, etc.
xperimental
factorsPBS and rL-CRBGP were added in HUVECs and CAM modelsxperimental
featuresProtein recombination, expression, separation, puriﬁcation and identiﬁcation.
Cell culture, tube formation and CAM model assayata source
locationDalian, Chinaata accessibility Data is with this articleD2. Value of the data These data are valuable for the soluble expression of the other CRISP family members.
 These data are valuable for the studies of the relationship between other CRISP family members
and angiogenesis.3. Data
As shown in Fig. 1, lamprey CRBGP is a very conservative gene and has 45% sequence identity with
the ES-CRISP from the snake venom of Echis carinatus sochureki. Subsequently, lamprey CRBGP was
subcloned into a pEGX-4T-1 vector and expressed as a Glutathione S-transferase (GST)-tagged fusion
protein in Rosetta blue cells with the molecular weight of 51.6 kDa (Fig. 2). After identiﬁcation by
matrix-assisted laser desorption/ionization time of ﬂight (MALDI-TOF/TOF) analysis, rL-CRBGP was
found to exhibit the anti-angiogenic activities in both tube formation and CAM assays (Figs. 3–5).4. Experimental design, materials and methods
4.1. Sequence alignment
Additional 10 CRISP sequences from the other species were obtained from ExPASy (http://www.
expasy.ch/tools/blast). The multiple sequence alignments of CRISPs were performed by ClustalX (1.81)
software using default settings [2].
4.2. Expression, puriﬁcation, and identiﬁcation of rL-CRBGP
A pair of PCR primers (CRBGP-F: 50-CCGGAATTCGCGAGCGTCGTGGCGGCGACA-30; CRBGP-R: 50-
AGAAGAATGCGGCCGCCTGCACATCCGTCG-30) was designed based on the sequence of lamprey CRBGP
[3], ﬂanked by an EcoR I and a Not I restriction site. Lamprey CRBGP was ampliﬁed and subcloned into
a pEGX-4T-1 vector with a GST-tag. rL-CRBGP was expressed in Rosetta blue cells induced with 1 mM
isopropyl-1-thio-β-D-galactopyranoside (IPTG) for 36 h. The cells were collected by centrifugation,
and washed in PBS for twice (pH 7.4). Subsequently, the cells were resuspended in the PBS (pH 7.4)
and sonicated on ice for 60 min. After centrifugation, the soluble supernatant was collected and
Fig. 1. Multiple sequence alignments of lamprey CRBGP with CRISPs from the other species by using ClustalX (1.81). The
accession numbers of the amino acid sequences extracted from the ExPASy database are as follows: Latisemin, Larimichthys
crocea, 808871467; CRISP-3, Homo sapiens, 1706135; ES-CRISP, Echis carinatus sochureki, sequence was extracted from Ref. [4];
VB-CRISP, Vipera berus, 487523159; Ablomin, Gloydius blomhofﬁi, 21305551; Stecrisp, Trimeresurus stejnegeri, 45476808; Natrin,
Naja atra, 32492059; Pseudechetoxin, Pseudechis australis, 23264042; Pseudecin, Pseudechis porphyriacus, 23264044; Helo-
thermine, Heloderma horridum, 606921; CRBGP, Lethenteron camtschaticum (Lampetra japonica), 145046200. Dashes represent
gaps inserted into the alignment. Identical residues are indicated by asterisks. Strong and weak homologous residues are
indicated in colons (:) and dots (.), respectively. The conserved cysteine residues are covered with gray boxes.
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Fig. 2. The expression and puriﬁcation of rL-CRBGP. The rL-CRBGP was separated by 12% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie brilliant blue R-250. Lane M, low molecular weight
protein marker; lane 1, crude lysate of Rosetta blue cells before IPTG induction (28 μg); lane 2, crude lysate of Rosetta blue cells
after induction with 1 mM IPTG for 36 h (30 μg); lane 3, precipitation from the induced Rosetta blue cells after sonication on ice
for 1 h (33 μg); lane 4, supernatant from the inducted Rosetta blue cells after sonication on ice for 1 h (28 μg); lane 5, the
puriﬁed rL-CRBGP (7.5 μg).
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Fig. 3. The recombinant protein was identiﬁed as rL-CRBGP by MALDI-TOF/TOF analysis.
Q. Jiang et al. / Data in Brief 6 (2016) 661–667664subjected to a GSTrapTM 4B column (GE, USA) equilibrated with binding buffer (PBS, pH 7.4). After
washing the column with wash buffer (PBS, pH 7.4), the rL-CRBGP was collected in elution buffer
containing 50 mM Tris–HCl, 20 mM glutathione (pH 8.0). The concentration of rL-CRBGP was also
measured using a bicinchoninic acid (BCA) protein assay Kit (Beyotime Biotechnology, China). The
puriﬁed rL-CRBGP was analyzed by 12% SDS-PAGE and stained with Coomassie brilliant blue R-250.
The rL-CRBGP was digested with trypsin (25 mM, Promega) in-gel overnight and identiﬁed by MALDI-
TOF/TOF mass spectrometry (Bruker, USA).4.3. Anti-angiogenic activity assay of rL-CRBGP
Similar to that of native lamprey CRBGP, the anti-angiogenic activity of rL-CRBGP was also per-
formed in both tube formation assay and CAM models according to the methods reported by Qi Jiang
and colleagues [1].
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Fig. 4. rL-CRBGP inhibited tube formation of HUVECs. Similar to the tube formation assay of native lamprey CRBGP [1], HUVECs
were also treated with PBS (panel A), 3 μM (panel B) or 6 μM (panel C) rL-CRBGP in the Matrigel-coated 24-well plates at 37 ˚C
for 16 h. After capturing the morphology of capillary-like tube through a microscope (Nikon, Japan), the vascular surface of
formed tubes per microscopic observation ﬁeld was counted and shown in panel D. The signiﬁcant differences between the PBS
and the rL-CRBGP treated groups were indicated with asterisks (***Po0.001).
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Fig. 5. rL-CRBGP inhibited basic ﬁbroblast growth factor (bFGF)-induced angiogenesis in CAM assays. Similar to the anti-
angiogenic assay of native lamprey CRBGP in CAM models, PBS (control) and rL-CRBGP (2, 10, 20 and 40 μM) were also added
onto the methylcellulose disc implanted into the bFGF-induced chick embryos at 37 ˚C for 24 h, respectively. When the
methylcellulose disc was removed, the chick embryos were captured by digital camera (Nikon, Japan).
Q. Jiang et al. / Data in Brief 6 (2016) 661–667666Acknowledgments
This work was supported by Grants from the National Natural Science Foundation of China (No.
31301880), the China Postdoctoral Science Foundation (No. 2013M541246), the Program for Liaoning
Excellent Talents in University (LJQ2015057), the New Teacher of Specialized Research Foundation for
the Doctoral Program of Higher Education of China (No. 20112136120002), the Scientiﬁc Research
Fund of Liaoning Provincial Education Department (No. L2011187), and the Scientiﬁc and Technolo-
gical Research Projects of Dalian (No. 2011J21DW014).Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.01.004.References
[1] Q. Jiang, Y. Liu, D. Duan, M. Gou, H. Wang, J. Wang, Q. Li, R. Xiao, Anti-angiogenic activities of CRBGP from buccal glands of
lampreys (Lampetra japonica) Biochimie, 2016 (in press).
Q. Jiang et al. / Data in Brief 6 (2016) 661–667 667[2] J.D. Thompson, T.J. Gibson, F. Plewniak, F. Jeanmougin, D.G. Higgins, The CLUSTAL_X windows interface ﬂexible strategies
for multiple sequence alignment aided by quality analysis tools, Nucl. Acids Res. 25 (1997) 4876–4882.
[3] N. Ito, M. Mita, Y. Takahashi, A. Matsushima, Y.G. Watanabe, S. Hirano, S. Odani, Novel cysteine-rich secretory protein in the
buccal gland secretion of the parasitic lamprey Lethenteron japonicum, Biochem. Biophys. Res. Commun. 358 (2007) 35–40.
[4] S. Lecht, R.A. Chiaverelli, J. Gerstenhaber, J.J. Calvete, P. Lazarovici, N.R. Casewell, R. Harrison, P.I. Lelkes, C. Marcinkiewicz,
Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki, Biochim. Biophys. Acta 1850
(2015) 1169–1179.
